[Bio Feature Article] ABio Materials Accelerates With Exosome Platform, Plans KOSDAQ Listing After Series C

ABio Materials, a Korean beauty-biotech startup, is expanding on a proprietary exosome platform as it prepares for a KOSDAQ listing next year. The company says it recently raised more than 10 billion in a Series C round, positioning the business to scale R&D, manufacturing and commercialization arou